Mycoplasma hyorhinis-Contaminated Cell Lines Activate Primary Innate Immune Cells via a Protease-Sensitive Factor

PLoS One. 2015 Nov 13;10(11):e0142523. doi: 10.1371/journal.pone.0142523. eCollection 2015.

Abstract

Mycoplasma are a frequent and occult contaminant of cell cultures, whereby these prokaryotic organisms can modify many aspects of cell physiology, rendering experiments that are conducted with such contaminated cells problematic. Chronic Mycoplasma contamination in human monocytic cells lines has been associated with suppressed Toll-like receptor (TLR) function. In contrast, we show here that components derived from a Mycoplasma hyorhinis-infected cell line can activate innate immunity in non-infected primary immune cells. Release of pro-inflammatory cytokines such as IL-6 by dendritic cells in response to Mycoplasma hyorhinis-infected cell components was critically dependent on the adapter protein MyD88 but only partially on TLR2. Unlike canonical TLR2 signaling that is triggered in response to the detection of Mycoplasma infection, innate immune activation by components of Mycoplasma-infected cells was inhibited by chloroquine treatment and sensitive to protease treatment. We further show that in plasmacytoid dendritic cells, soluble factors from Mycoplasma hyorhinis-infected cells induce the production of large amounts of IFN-α. We conclude that Mycoplasma hyorhinis-infected cell lines release protein factors that can potently activate co-cultured innate immune cells via a previously unrecognized mechanism, thus limiting the validity of such co-culture experiments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cell Line, Tumor
  • Cells, Cultured
  • Coculture Techniques
  • Dendritic Cells / immunology
  • Female
  • Humans
  • Immunity, Innate*
  • Interferon-alpha / immunology
  • Interleukin-6 / immunology*
  • Mice, Inbred C57BL
  • Mycoplasma Infections / immunology*
  • Mycoplasma hyorhinis / immunology*
  • Myeloid Differentiation Factor 88 / immunology*
  • Toll-Like Receptor 2 / immunology*

Substances

  • Interferon-alpha
  • Interleukin-6
  • Myeloid Differentiation Factor 88
  • Toll-Like Receptor 2

Grants and funding

This work was supported by grants from the Swiss National Science Foundation (project 138284 to C.B.), the Swiss Foundation for Cancer Research (grant KFS-2910-02-2012 to C.B. and C.H.), and the German Research Foundation (DFG) Graduiertenkolleg 1202 (to C.B., S.E., and S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.